Advertisement
News
Subscribe to MDT Magazine News

DJO Surgical, a DJO Global Company, Announces the First TaperFill Hip Stem Implanted

July 29, 2013 7:35 am | by Business Wire | Comments

DJO Global, Inc., a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, announced that the first TaperFill™ Total Hip Replacement (THR) was implanted. TaperFill was developed to accommodate a minimally invasive procedure.

TOPICS:

MedConnections Released PACE Health Connect App To Allow Patients To Manage Health Care Faster And Easier

July 29, 2013 6:00 am | by PR Newswire | Comments

MedConnections launched its new mobile app, PACE Health Connect, featuring a patent pending interactive messaging system. Enterprise customers can provide employees, patients and members interactive messaging on 35 medical conditions with over 1,000 different messages, alerts and reminders to enhance their disease and lifestyle management.

TOPICS:

RainDrop System Unlocks Power of Trovagene's Urine-Based Mutation Detection Technology

July 29, 2013 5:00 am | by PR Newswire | Comments

Trovagene, Inc. (NASDAQ: TROV) and RainDance Technologies announced today that Trovagene has adopted RainDance's RainDropTM Digital PCR System for research and development, and for eventual use in the Trovagene CLIA laboratory.  Trovagene has also announced successful development of a cell-free DNA mutation assay leveraging the RainDrop platform.

TOPICS:
Advertisement

Public Workshop - The Patient Preference Initiative: Incorporating Patient Preference Information into the Medical Device Regulatory Processes, September 18-19, 2013

July 29, 2013 12:00 am | by U.S. Food & Drug Administration | Comments

The purpose of this workshop is to discuss ways to incorporate patient preferences on the benefit-risk trade-offs of medical devices into the full spectrum of the Center for Devices and Radiological Heath (CDRH) regulatory decision making. It also aims...

TOPICS:

Class I Medical Device Recall: GE Healthcare Nuclear Medicine Systems

July 29, 2013 12:00 am | by U.S. Food & Drug Administration | Comments

Reason for Recall: GE Healthcare became aware of an incident at a VA Medical Center facility in the US. A patient died due to injuries sustained while being scanned on an Infinia Hawkeye 4 Nuclear Medicine System. On July 03, 2013 GE notified hospitals...

TOPICS:

Hacker Discussing Hacking Pacemakers Dies

July 27, 2013 1:29 am | by Sudhin Thanawala - Associated Press | Comments

A prominent hacker who discovered a way to have automatic teller machines spit out cash and was set to deliver a talk about hacking pacemakers and other wireless implantable medical devices has died in San Francisco, authorities and his employer said.

TOPICS:

Medicare Policies Restricting Power Wheelchair Repairs Leave Vulnerable Beneficiaries with Limited Mobility

July 26, 2013 2:52 pm | by PR Newswire | Comments

For years, William Welch, 58, was a truck driver, a free spirit traveling along the roads. But now Welch spends his days in a Brunswick, Md. apartment, barely able to move from a chair to the refrigerator because his Medicare-supplied power wheelchair is broken and he can't find anyone to fix it, says the American Association for Homecare (AAHomecare).

TOPICS:

DJO Global ‘Stimulates’ Total Knee and ACL Rehabilitation Market

July 26, 2013 1:17 pm | by DJO Global | Comments

DJO Global has announced the launch of the Empi Phoenix, an electrical stimulator designed to help simplify treatment of muscle atrophy before and after surgery for total knee replacement or ACL repair.        

TOPICS:
Advertisement

Zimmer settles lawsuit against surgeon, knee implant inventor

July 26, 2013 1:07 pm | by Mass Device | Comments

Zimmer settled a lawsuit with a prominent orthopedic surgeon who claimed a right to royalties for his work on some of the medical device company's knee implants, agreeing to dismiss the case with prejudice. Dr. Norman Scott sought to be included in a trio patents along with another physician, Dr. Giles Scuderi.

TOPICS:

Weight loss: FDA accepts EnteroMedics' submission of VBLOC neurostim implant

July 26, 2013 12:45 pm | by Mass Device | Comments

Minnesota medical devices maker EnteroMedics touted today that the FDA had accepted for review the company's premarket approval submission of the Maestro Rechargeable System's VBLOC implant, a neurostimulation device for treating obesity.   

TOPICS:

A Faster Vessel for Charting the Brain

July 26, 2013 12:21 pm | by Morgan Kelly, Princeton University | Comments

Princeton University researchers have created “souped up” versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.     

TOPICS:

Polymer Ribbons for Better Healing

July 26, 2013 12:12 pm | by Albert-Ludwigs-Universität Freiburg | Comments

Freiburg researchers develop hydrogels for tissue regeneration that can be fine-tuned to fit any body part. A new kind of gel that promotes the proper organization of human cells has been developed by Prof. Prasad Shastri of the Institute of Macromolecular Chemistry and BIOSS Centre for Biological Signalling Studies Excellence Cluster at the University of Freiburg.

TOPICS:

Panasonic to Sell Part of Healthcare Business

July 26, 2013 11:49 am | by The Associated Press | Comments

Panasonic said Friday it will sell its ultrasonic diagnostic equipment business to Konica Minolta Inc. in January 2014 as part of efforts to improve its financial base eroded by the firm's recent sluggish performance.     

TOPICS:

Cepheid Receives FDA Market Authorization for Xpert MTB/RIF

July 26, 2013 11:45 am | by Cepheid | Comments

Cepheid has announced that it has received market authorization from the U.S. Food & Drug Administration (FDA) for its Xpert MTB/RIF test. The review decision was based on the de novo 510(k) review process, which allows novel products without predicates to be down-classified and brought to market.

TOPICS:

Teaching Old Drugs New Tricks

July 26, 2013 9:52 am | by Cambridge Consultants | Comments

Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading